Otto Mayer1,2, Jan Bruthans1,3, Simona Bilkova1,2, Jitka Seidlerova1,2, Josef Jirak4, Jan Filipovsky1,2. 1. 2nd Department of Internal Medicine, Faculty of Medicine, Charles University and University Hospital, Pilsen, Czech Republic. 2. Biomedical Center, Faculty of Medicine, Charles University Pilsen, Czech Republic. 3. Centre for Cardiovascular Prevention, First Faculty of Medicine, Charles, University and Thomayer's Hospital, Prague, Czech Republic. 4. Department of Informatics, University Hospital Pilsen, Czech Republic.
Abstract
AIMS: We analyzed the mortality risk and its predictors in patients hospitalized for heart failure (HF). METHODS: Patients discharged from hospitalization for acute decompensation of HF in 2010-2020 and younger than 86 years were followed (n=4097). We assessed the incidence and trends of all-cause death, its main predictors, and the pharmacotherapy recommended at discharge from the hospital. RESULTS: The 30 days all-cause mortality was in discharged patients 3.2%, while 1-year 20.4% and 5-years 55.4%. We observed a modest trend to decreased 1-year mortality risk over time. Any increase of year of hospitalization by one was associated with about 5% lower risk in the fully adjusted model. Regarding predictors of 1-year mortality risk, a positive association was found for age over 65, history of malignancy, and peak brain natriuretic peptide during hospitalization ≥10times higher than normal concentration. In contrast, as protective factors, we identified LDL ≥1.8 mmol/L, treatment with beta-blockers, renin-angiotensin axis blockers, statins, and implanted cardioverter in the same regression model. The ejection fraction category and primary etiology of HF (coronary artery disease vs. others) did not significantly affect the mortality risk in a fully adjusted model. CONCLUSIONS: Despite advances in cardiovascular disease management over the last two decades, the prognosis of patients hospitalized for heart failure remained highly unfavorable.
AIMS: We analyzed the mortality risk and its predictors in patients hospitalized for heart failure (HF). METHODS: Patients discharged from hospitalization for acute decompensation of HF in 2010-2020 and younger than 86 years were followed (n=4097). We assessed the incidence and trends of all-cause death, its main predictors, and the pharmacotherapy recommended at discharge from the hospital. RESULTS: The 30 days all-cause mortality was in discharged patients 3.2%, while 1-year 20.4% and 5-years 55.4%. We observed a modest trend to decreased 1-year mortality risk over time. Any increase of year of hospitalization by one was associated with about 5% lower risk in the fully adjusted model. Regarding predictors of 1-year mortality risk, a positive association was found for age over 65, history of malignancy, and peak brain natriuretic peptide during hospitalization ≥10times higher than normal concentration. In contrast, as protective factors, we identified LDL ≥1.8 mmol/L, treatment with beta-blockers, renin-angiotensin axis blockers, statins, and implanted cardioverter in the same regression model. The ejection fraction category and primary etiology of HF (coronary artery disease vs. others) did not significantly affect the mortality risk in a fully adjusted model. CONCLUSIONS: Despite advances in cardiovascular disease management over the last two decades, the prognosis of patients hospitalized for heart failure remained highly unfavorable.
Authors: Otto Mayer; Jitka Seidlerová; Jan Bruthans; Jan Opatrný; Milan Hromádka; Josef Jirák; Jan Filipovský Journal: J Comp Eff Res Date: 2021-02-05 Impact factor: 1.744
Authors: Biykem Bozkurt; Andrew J S Coats; Hiroyuki Tsutsui; Ca Magdy Abdelhamid; Stamatis Adamopoulos; Nancy Albert; Stefan D Anker; John Atherton; Michael Böhm; Javed Butler; Mark H Drazner; G Michael Felker; Gerasimos Filippatos; Mona Fiuzat; Gregg C Fonarow; Juan-Esteban Gomez-Mesa; Paul Heidenreich; Teruhiko Imamura; Ewa A Jankowska; James Januzzi; Prateeti Khazanie; Koichiro Kinugawa; Carolyn S P Lam; Yuya Matsue; Marco Metra; Tomohito Ohtani; Massimo Francesco Piepoli; Piotr Ponikowski; Giuseppe M C Rosano; Yasushi Sakata; Petar Seferović; Randall C Starling; John R Teerlink; Orly Vardeny; Kazuhiro Yamamoto; Clyde Yancy; Jian Zhang; Shelley Zieroth Journal: Eur J Heart Fail Date: 2021-03-03 Impact factor: 15.534
Authors: K MacIntyre; S Capewell; S Stewart; J W Chalmers; J Boyd; A Finlayson; A Redpath; J P Pell; J J McMurray Journal: Circulation Date: 2000-09-05 Impact factor: 29.690
Authors: Christoph Ohlmeier; Rafael Mikolajczyk; Johann Frick; Franziska Prütz; Wilhelm Haverkamp; Edeltraut Garbe Journal: Clin Res Cardiol Date: 2015-03-17 Impact factor: 5.460
Authors: Theresa A McDonagh; Marco Metra; Marianna Adamo; Roy S Gardner; Andreas Baumbach; Michael Böhm; Haran Burri; Javed Butler; Jelena Čelutkienė; Ovidiu Chioncel; John G F Cleland; Andrew J S Coats; Maria G Crespo-Leiro; Dimitrios Farmakis; Martine Gilard; Stephane Heymans; Arno W Hoes; Tiny Jaarsma; Ewa A Jankowska; Mitja Lainscak; Carolyn S P Lam; Alexander R Lyon; John J V McMurray; Alexandre Mebazaa; Richard Mindham; Claudio Muneretto; Massimo Francesco Piepoli; Susanna Price; Giuseppe M C Rosano; Frank Ruschitzka; Anne Kathrine Skibelund Journal: Eur Heart J Date: 2021-09-21 Impact factor: 29.983
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391